Chemical Compound Review:
Succinobucol 4-[4-[2-(4-hydroxy-3,5- ditert-butyl...
Synonyms:
CHEMBL83626, AGI-1067, AGZ-1067, AG-K-57691, AGI1067, ...
Tardif,
Hatch,
Wasserman,
Sundell,
Kunsch,
Edwards,
Meng,
Medford,
Tardif,
Tardif,
Grégoire,
L'Allier,
Doggrell,
Tardif,
Grégoire,
Lavoie,
L'Allier,
Kunsch,
Luchoomun,
Grey,
Olliff,
Saint,
Arrendale,
Wasserman,
Saxena,
Medford,
Sundell,
Somers,
Meng,
Hoong,
Suen,
Hill,
Landers,
Chapman,
Butteiger,
Jones,
Edwards,
Daugherty,
Wasserman,
Alexander,
Medford,
Saxena,
- Clinical results with AGI-1067: a novel antioxidant vascular protectant. Tardif, J.C. Am. J. Cardiol. (2003)
- The In Vitro Effects of a Novel Vascular Protectant, AGI-1067, on Platelet Aggregation and Major Receptor Expression in Subjects With Multiple Risk Factors for Vascular Disease. Serebruany, V., Malinin, A., Scott, R. J. Cardiovasc. Pharmacol. Ther. (2006)
- AGI-1067. AtheroGenics. Hatch, G.M. Current opinion in investigational drugs (London, England : 2000) (2002)
- Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies. Tardif, J.C., Grégoire, J., Lavoie, M.A., L'Allier, P.L. Curr. Opin. Lipidol. (2003)
- Selective inhibition of endothelial and monocyte redox-sensitive genes by AGI-1067: a novel antioxidant and anti-inflammatory agent. Kunsch, C., Luchoomun, J., Grey, J.Y., Olliff, L.K., Saint, L.B., Arrendale, R.F., Wasserman, M.A., Saxena, U., Medford, R.M. J. Pharmacol. Exp. Ther. (2004)
- AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agent. Sundell, C.L., Somers, P.K., Meng, C.Q., Hoong, L.K., Suen, K.L., Hill, R.R., Landers, L.K., Chapman, A., Butteiger, D., Jones, M., Edwards, D., Daugherty, A., Wasserman, M.A., Alexander, R.W., Medford, R.M., Saxena, U. J. Pharmacol. Exp. Ther. (2003)
- Prevention of restenosis with antioxidants: mechanisms and implications. Tardif, J.C., Grégoire, J., L'Allier, P.L. American journal of cardiovascular drugs : drugs, devices, and other interventions. (2002)
- Experimental and clinical studies show that the probucol derivative AGI-1067 prevents vascular growth. Doggrell, S.A. Expert opinion on investigational drugs. (2003)
- Antioxidants: The good, the bad and the ugly. Tardif, J. The Canadian journal of cardiology. (2006)
- Chemistry and pharmacology of vascular protectants: a novel approach to the treatment of atherosclerosis and coronary artery disease. Wasserman, M.A., Sundell, C.L., Kunsch, C., Edwards, D., Meng, C.Q., Medford, R.M. Am. J. Cardiol. (2003)